Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of the present study was to compare the effects of electro-acupuncture at different points on nociceptive responses of VB neurons. The experiments were carried out on rats (280-320g) anaesthetized with urethane (19/kg,i.p.). Single unit activities of VB neurons were extracellularly recorded by means of glass microelectrodes. Noxious stimulation was subcutaneously applied at the left ankle joint by inserting two stainless needles. The experiments were divided into three groups: EA. I, EA. II and EA. III. The corresponding points being selected for electroacupuncture in the above three groups were the left "Huantiao" (G30) point, the right "Huantiao" point and the left "Jianlian" (
T14
) point. The results showed that electroacupuncture at the points in the three groups all could inhibit the nociceptive responses of VB neurons, but electroacupuncture an the left "Huantiao" point (n = 11) was more effective than either at the right "Huantian" point (n = 9) or at the left "Jianliao" point (n = 10). There was a significant difference among the three groups. However, there was no significant difference between EA. II and EA. III. Thus, the results indicate that there is a relative specificity of points in acupuncture
analgesia
.
...
PMID:[Effects of electroacupuncture at different points on nociceptive responses of the ventro-basal complex]. 187 99
Six adult horses were used to compare the effects of segmental epidural
analgesia
(SEA) and segmental subarachnoid
analgesia
(SSA). A 17-gauge Huber point directional needle was used to place a catheter with stylet into the epidural space or the subarachnoid space at the lumbosacral intervertebral junction and to catheterize the thoracolumbar epidural or subarachnoid space. The position of the catheter was confirmed radiographically. A 2% solution of mepivacaine hydrochloride was used at average doses of 80 mg (4 ml) to produce SEA and 30 mg (1.5 ml) to produce SSA. Onset of
analgesia
in response to superficial and deep muscular pinprick stimulations was significantly (P less than 0.05) faster in horses with SSA than with SEA (8.0 +/- 1.9 minutes vs 15.8 +/- 3.8 minutes). Maximal thoracolumbar
analgesia
extended from spinal cord segments
T14
to L3 on both sides of the spinal column during SSA and from T12 to L2 on one or both sides during SEA. Duration of
analgesia
lasted significantly (P less than 0.05) longer in horses with SEA than in those with SSA (80.8 +/- 16.9 minutes vs 44.8 +/- 14.5 minutes). There was a significant (P less than 0.05) increase in subcutaneous temperature at the right and left 18th thoracic (T18) dermatomes and decreases of respiratory rate and rectal temperatures in horses with SEA. Respiratory rate and rectal temperature were not significantly (P greater than 0.05) decreased in horses with SSA.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Segmental epidural and subarachnoid analgesia in conscious horses: a comparative study. 663 47
Seven adult mares were used to determine the analgesic, CNS, and cardiopulmonary effects of detomidine hydrochloride solution after epidural or subarachnoid administration, using both regimens in random sequence. At least 1 week elapsed between experiments. A 17-gauge Huber point (Tuohy) directional needle was used to place a catheter with stylet into either the epidural space at the first coccygeal interspace or the subarachnoid space at the lumbosacral intervertebral junction. Catheters were advanced so that the tips lay at the caudal sacral (S5 to S4) epidural space or at the midsacral (S3 to S2) subarachnoid space. Position of the catheter was confirmed radiographically. A 1% solution of detomidine HCl was injected into the epidural catheter at a dosage of 60 micrograms/kg of body weight, and was expanded to a 10-ml volume with sterile water to induce selective caudal epidural
analgesia
(CEA). A dose of 30 micrograms of detomidine HCl/kg expanded to a 3-ml volume with spinal fluid was injected into the subarachnoid catheter to induce caudal subarachnoid
analgesia
(CSA).
Analgesia
was determined by lack of sensory perception to electrical stimulation (avoidance threshold > 40 V, 0.5-ms duration) at the perineal dermatomes and no response to superficial and deep muscular pinprick stimulation at the pelvic limb and lumbar and thoracic dermatomes. Maximal CEA and CSA extended from the coccyx to spinal cord segments T15 and
T14
at 10 to 25 minutes after epidural and subarachnoid drug administrations in 2 mares.
Analgesia
at the perineal area lasted longer after epidural than after subarachnoid administration (142.8 +/- 28.8 minutes vs 127.1 +/- 27.7 minutes). All mares remained standing. Both CEA and CSA induced marked sedation, moderate ataxia, minimal cardiopulmonary depression, increased frequency of second-degree atrioventricular heart block, and renal diuresis. All treatments resulted in significantly (P < 0.05) decreased heart rate, respiratory rate, systemic arterial blood pressure, PCV, and plasma total solids concentration. To the contrary, arterial carbon dioxide tension, plasma bicarbonate, and standard base excess concentrations were significantly (P < 0.05) increased. Arterial oxygen tension, pH, and rectal temperature did not change significantly from baseline values. Results indicate that use of detomidine for CEA and CSA in mares probably induces local spinal and CNS effects, marked sedation, moderate ataxia, mild cardiopulmonary depression, and renal diuresis.
...
PMID:Caudal analgesia induced by epidural or subarachnoid administration of detomidine hydrochloride solution in mares. 806 16